Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Polyphenols and Insulin Resistance (POLYOXRESIST)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT01478841
First received: November 21, 2011
Last updated: February 10, 2012
Last verified: February 2012